2015年10月7日 中国北京 法国巴黎 —— 思凌创展作为帮助客户在医疗保健领域实现商业化的前端服务伙伴，宣布在中国和印度取得了一项非介入筛查体内重金属含量技术的专利权。这项技术由一个分光光度仪和软件即服务（SaaS）模式构成。它具备检测体内重金属和微量元素含量的功能，并将在以Oligoscan® 欧立健™品牌投入中国市场。该产品为欧洲制造，且已经取得了CE认证标志和ISO13485标准。 思凌创展总经理Gaëtan de KERROS补充道：
SPIREN Ventures acquires the Exclusive Rights of a Digital Health technology, screening Heavy Metals, in China and India.
by Spiren 1 comments
Beijing (China), Paris (France), October 7, 2015 – SPIREN Ventures, a Commercialization Front Office, specialized in HealthCare, announces the acquisition of the Exclusive Rights of a non-invasive technology screening Heavy Metals, in China and India. This technology is comprised of a medical device and a Service as a Software (SaaS) model. It screens heavy metals and mineral deficiencies, and will be marketed in China under the brand Oligoscan® 欧立健™. Made in Europe, it has been granted CE mark, and ISO 13485 certificate. Gaëtan de KERROS, Managing Director of SPIREN Ventures, adds up: “recent government initiatives, traditional and social medias have raised exceptional awareness around pollution particularly in China and India. This non-invasive and connected technology helps screen Heavy Metals as well as Mineral Deficiencies among a large population. It provides a comprehensive report which contributes to achieve a balanced nutrition and healthy life style”.
Beijing (China), Paris (France), September 30, 2015 – SPIREN HealthCare, a strategy consulting firm specialized in Life Science industries and TONGTAI Uni-trust HealthCare Investing Co. Ltd, a Mergers & Acquisitions firm, announce a partnership today. This aims at partnering with CEO’s of Life Science companies looking for Mergers & Acquisitions and fund raising in China. This Partnership is grounded in a rare combination of healthcare Expertise, Experience track records and exceptional Network in China with Strategic and Financial Investors.
Pleased to share the news! Guerbet (GBT) announced today the signing of an agreement with Beijing Kyuan Pharmaceutical Co., Ltd., one of the major pharmaceutical drugs distributors & importers in the Chinese market, to distribute & commercialize Lipiodol® Ultra-Fluid as from September 2015. Founded in 1995, Kyuan is part of the Shanghai Pharma group (SPH) - China’s second biggest pharmaceutical distribution group - since 2011. This agreement enables Guerbet flagship Interventional Radiology agent to benefit from Kyuan’s outstanding experience in distributing pharmaceuticals on the hospital market.